Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Mooberry

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Journal of Natural Products|June 26, 2004
A new dimension to the biosynthetic products isolated from the sponge Negombata magnificaBoaz Vilozny, Taro Amagata, Susan L Mooberry, et al.
Cancer Treatment Reviews|January 2, 2009
Microtubule dynamics as a target in oncologyApril L Risinger, Francis J Giles, Susan L Mooberry
Oncotarget|February 22, 2018
Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulinNicholas F Dybdal-Hargreaves, April L Risinger, Susan L Mooberry
Oncotarget|August 7, 2019
Correction: Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulinNicholas F Dybdal-Hargreaves, April L Risinger, Susan L Mooberry
Cancers|July 2, 2021
Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer CellsPetra J Pederson, Huiyun Liang, Daria Filonov, et al.
Anticancer Research|October 28, 2015
Breast Cancer Cell Lines Exhibit Differential Sensitivities to Microtubule-targeting Drugs Independent of Doubling TimeApril L Risinger, Nicholas F Dybdal-Hargreaves, Susan L Mooberry
Journal of Natural Products|July 17, 2013
Hydrolysis reactions of the taccalonolides reveal structure-activity relationshipsJing Li, Jiangnan Peng, April L Risinger, et al.
Journal of Medicinal Chemistry|June 25, 2014
Synthetic reactions with rare taccalonolides reveal the value of C-22,23 epoxidation for microtubule stabilizing potencyJiangnan Peng, April L Risinger, Jing Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2015
Eribulin mesylate: mechanism of action of a unique microtubule-targeting agentNicholas F Dybdal-Hargreaves, April L Risinger, Susan L Mooberry
Cancer Letters|April 22, 2011
The taccalonolides, novel microtubule stabilizers, and γ-radiation have additive effects on cellular viabilityApril L Risinger, Mohan Natarajan, Charles R Thomas, et al.
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Journal of Natural Products|June 26, 2004
A new dimension to the biosynthetic products isolated from the sponge Negombata magnificaBoaz Vilozny, Taro Amagata, Susan L Mooberry, et al.
Cancer Treatment Reviews|January 2, 2009
Microtubule dynamics as a target in oncologyApril L Risinger, Francis J Giles, Susan L Mooberry
Oncotarget|February 22, 2018
Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulinNicholas F Dybdal-Hargreaves, April L Risinger, Susan L Mooberry
Oncotarget|August 7, 2019
Correction: Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulinNicholas F Dybdal-Hargreaves, April L Risinger, Susan L Mooberry
Cancers|July 2, 2021
Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer CellsPetra J Pederson, Huiyun Liang, Daria Filonov, et al.
Anticancer Research|October 28, 2015
Breast Cancer Cell Lines Exhibit Differential Sensitivities to Microtubule-targeting Drugs Independent of Doubling TimeApril L Risinger, Nicholas F Dybdal-Hargreaves, Susan L Mooberry
Journal of Natural Products|July 17, 2013
Hydrolysis reactions of the taccalonolides reveal structure-activity relationshipsJing Li, Jiangnan Peng, April L Risinger, et al.
Journal of Medicinal Chemistry|June 25, 2014
Synthetic reactions with rare taccalonolides reveal the value of C-22,23 epoxidation for microtubule stabilizing potencyJiangnan Peng, April L Risinger, Jing Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2015
Eribulin mesylate: mechanism of action of a unique microtubule-targeting agentNicholas F Dybdal-Hargreaves, April L Risinger, Susan L Mooberry
Cancer Letters|April 22, 2011
The taccalonolides, novel microtubule stabilizers, and γ-radiation have additive effects on cellular viabilityApril L Risinger, Mohan Natarajan, Charles R Thomas, et al.
Pageof 12